Evidence map›Paper›PMID 31616784›Full record

ArticleScience advances2019

HIV-1 Gag specifically restricts PI(4,5)P2 and cholesterol mobility in living cells creating a nanodomain platform for virus assembly.

C Favard, J Chojnacki, P Merida, N Yandrapalli, J Mak, C Eggeling, D Muriaux

Open access · goldAbstract read
In one paragraph

Article in Science advances, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 54 papers.

0numbers the graph read from it
0cells of the map it votes in
54citing papers in PubMed
4.8field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

54 citing papers in PubMed, 87 citations in OpenAlex.

  1. Mechanisms of HIV-1 assembly, release and maturation.Nature reviews. Microbiology · 2026
    Review
  2. Review
  3. Review
  4. Article
  5. Article
  6. PIPScience advances · 2025
    Article
  7. Article
  8. Article
  9. HIV-1 budding requires cortical actin disassembly by the oxidoreductase MICAL1.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Phosphatidylinositol-3-phosphate mediates Arc capsid secretion through the multivesicular body pathway.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  16. Cooperative Membrane Binding of HIV-1 Matrix Proteins.The journal of physical chemistry. B · 2024
    Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 5 countries.

C FavardMontpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.ORCID 0000-0002-8304-2980
J ChojnackiMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.ORCID 0000-0002-4457-8096
P MeridaMontpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.
N YandrapalliMontpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.ORCID 0000-0002-1516-6674
J MakInstitute for Glycomics, Griffith University Gold Coast, Southport, QLD, Australia.ORCID 0000-0002-5229-5707
C EggelingMRC Human Immunology Unit, Weatherall Institute of Molecular Medicine, University of Oxford, Oxford OX3 9DS, UK.ORCID 0000-0002-3698-5599
D MuriauxMontpellier Infectious Disease Research Institute, IRIM, CNRS-Université Montpellier, 1919, route de Mende, 34293 Montpellier Cedex, France.ORCID 0000-0001-8517-9342
Centre National de la Recherche Scientifique · FRGriffith University · AULeibniz Institute of Photonic Technology · DEUniversity of Oxford · GB

Funding

Targeting Drug Resistance in HIV-1 ProteaseR01GM064347 · NIGMS · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SCHIFFER, CELIA A. · 2001 to 2013
$4.5M
Medical Research Council G0902418Medical Research Council MC_UU_00008/9Medical Research Council MC_UU_12010/9Medical Research Council MR/K01577X/1NIGMS NIH HHS R01 GM064347Wellcome Trust
6 · The paper itself

Abstract

HIV-1 Gag protein assembles at the plasma membrane of infected cells for viral particle formation. Gag targets lipids, mainly PI(4,5)P2, at the inner leaflet of this membrane. Here, we address the question whether Gag is able to trap specifically PI(4,5)P2 or other lipids during HIV-1 assembly in the host CD4

Indexed as

Virus AssemblyCD4-Positive T-LymphocytesCell SurvivalCholesterolDiffusiongag Gene Products, Human Immunodeficiency VirusHIV-1HumansJurkat CellsNanoparticlesPhosphatidylinositol 4,5-DiphosphateSphingomyelinsVirionCholesterolgag Gene Products, Human Immunodeficiency VirusPhosphatidylinositol 4,5-DiphosphateSphingomyelins

Identifiers

PMID31616784
PMCPMC6774721
OpenAlexW2977367470

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.